AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,542,663 | -61.3% | 4,160,292 | -32.8% | 0.00% | -75.0% |
| Q2 2023 | $68,642,586 | +2.2% | 6,189,593 | +41.4% | 0.00% | 0.0% |
| Q1 2023 | $67,187,871 | -57.6% | 4,377,060 | -38.7% | 0.00% | -20.0% |
| Q4 2022 | $158,442,236 | +451.2% | 7,140,254 | +305.6% | 0.01% | +150.0% |
| Q3 2022 | $28,746,000 | +7.7% | 1,760,331 | -4.2% | 0.00% | 0.0% |
| Q2 2022 | $26,701,000 | -12.0% | 1,837,675 | +11.9% | 0.00% | +100.0% |
| Q1 2022 | $30,325,000 | -8.7% | 1,641,867 | +17.5% | 0.00% | -50.0% |
| Q4 2021 | $33,216,000 | -5.6% | 1,397,403 | -2.2% | 0.00% | 0.0% |
| Q3 2021 | $35,196,000 | +6.1% | 1,429,004 | +6.4% | 0.00% | 0.0% |
| Q2 2021 | $33,188,000 | +12.8% | 1,343,118 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $29,415,000 | +69.3% | 1,348,673 | +98.0% | 0.00% | +100.0% |
| Q4 2020 | $17,379,000 | +152.6% | 680,994 | +178.6% | 0.00% | – |
| Q3 2020 | $6,881,000 | – | 244,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |